- Home
- TTOO
TTOO
T2 Biosystems Inc.
as 12-18-2024 2:43pm EST
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | LEXINGTON |
| Market Cap: | 10.7M | IPO Year: | 2014 |
| Target Price: | $5.00 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.31 - $8.38 | Next Earning Date: | 02-13-2025 |
| Revenue: | $7,677,000 | Revenue Growth: | -30.19% |
| Revenue Growth (this year): | 50.31% | Revenue Growth (next year): | 117.92% |
Latest T2 Biosystems Inc. News
TTOO Breaking Stock News: Dive into TTOO Ticker-Specific Updates for Smart Investing
GlobeNewswire
8 hours ago
T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor
GlobeNewswire
a day ago
T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally
MT Newswires
2 days ago
T2 Biosystems Extends Capital Equipment Supplier Deal With Vizient; Shares Rise
GlobeNewswire
2 days ago
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
GlobeNewswire
9 days ago
T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens
GuruFocus.com
a month ago
T2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...
Associated Press Finance
a month ago
T2 Biosystems: Q3 Earnings Snapshot
GlobeNewswire
a month ago
T2 Biosystems Announces Third Quarter 2024 Financial Results
Compare TTOO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TTOO T2 Biosystems Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.